 |
|
|
| |
Real-World Assessment of Renal and Bone Safety Among Patients Exposed to
Tenofovir Disoproxil Fumarate-Containing Single Tablet Regimens
|
| |
| |
Reported by Jules Levin
Presented at: ASM Microbe 2016, June 16-20, 2016, Boston, MA
Ella Nkhoma, PhD;1 Lisa Rosenblatt, MD, MPH;2 Joel Myers, MPharm;2 John Coumbis, MD, MPH;3
1Bristol-Myers Squibb, Wallingford, CT, USA; 2Bristol Myers Squibb, Plainsboro, NJ, USA; 3Bristol Myers Squibb, Hopewell, NJ, USA.
Among patients prescribed STRs, significant risk factors for fracture identified on
univariate analysis were older age and a history of substance abuse (Figure 2)
|
| |
|
|
|
|
|
